The next board meeting for Lexicon Pharma Inc is on 19 May 2026 for the purpose of 4th Annual H.C. Wainwright BioConnect Investor ConferenceSee details
Lexicon Pharma Inc has a share price target of US$ 4, revenue growth forecast of -23.4%, and profit growth estimate of -33.0% for FY26, based on top 5 analyst calls.